Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

NCT02271360 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT02271360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
Lead sponsor
Benha University
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2014
Completion date
December 31, 2015
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility